Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 376 Polycystic Ovary Syndrome 40 Neoplasm Metastasis 23 Endometrial Neoplasms 22 Ovarian Neoplasms 16 Neoplasms 14 Infertility 11 Advanced Breast Cancer 10 Fallopian Tube Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Osteoporosis 7 Carcinoma, Ductal, Breast 7 Breast Neoplasms, Male 7 Breast Diseases 7 Carcinoma, Lobular 6 Breast Carcinoma In Situ 6 Prostatic Neoplasms 5 Leiomyoma 4 Infertility, Female 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Cancer Metastatic 4 Arthralgia 4 Obesity 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2

Interventions

Blood Specimen Collection 29 Reverse Transcriptase Polymerase Chain Reaction 7 Flow Cytometry 7 Surgical Procedures, Operative 4 Liquid Biopsy 4 cabazitaxel 3 Trastuzumab 3 Propofol 3 Carboplatin 3 Bevacizumab 3 Standard of Care 2 Spinal Puncture 2 Sevoflurane 2 Positron Emission Tomography Computed Tomography 2 Pirinitramide 2 Neoadjuvant Therapy 2 Morphine 2 Laparoscopy 2 Hematologic Tests 2 Gemcitabine 2 Folfox protocol 2 Epirubicin 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 Capecitabine 2 Aspirin 2 Anesthesia, General 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × Letrozole × Clear all

NCT02958852 2025-09-10

ABC-SE

Lund University Hospital

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡